|
|
|
|
|
|
By Francisco Conesa Buendía | For all its patient-centered benefits, producing personalized medicine at the point of care has pitfalls that are worth careful consideration. | |
|
|
|
|
|
|
By Erin Harris, Editor-In-Chief, Cell & Gene | Atsena Therapeutics exemplifies the field’s growing shift toward non-oncology indications with its targeted gene therapy for X-linked retinoschisis, a rare inherited retinal disorder with no approved treatments. | |
|
|
|
|
|
|
| Demystifying Cell & Gene Therapy In Australia And APAC | Article | By Dr. Jorgen Mould and Dr. Jennifer Hollands, Avance Clinical | Though conducting your clinical trial in Australia may initially seem daunting, the benefits are ample. Australia is home to qualified CRO partners that will guide your CGT to regulatory success. |
|
|
| Navigating Viral Characterization | e-book | Bio-Rad Laboratories, Inc. | Explore how clinicians are tackling challenges in developing AAV vectors for use in gene therapy, working around hurdles to help these vectors meet their full potential to treat rare diseases. |
|
|
|
CLINICAL TRIALS SOLUTIONS |
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
